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Embryonic exposure to the endocrine disruptor vinclozolin during gonadal sex determination appears to promote an epigenetic reprogramming
of the male germ line that is associated with transgenerational adult-onset disease states. Transgenerational effects on the embryonic day 16 (E16)
testis demonstrated reproducible changes in the testis transcriptome for multiple generations (F1–F3). The expression of 196 genes was found to
be influenced, with the majority of gene expression being decreased or silenced. Dramatic changes in the gene expression of methyltransferases
during gonadal sex determination were observed in the F1 and F2 vinclozolin generation (E16) embryonic testis, but the majority returned to
control-generation levels by the F3 generation. The most dramatic effects were on the germ-line-associated Dnmt3A and Dnmt3L isoforms.
Observations demonstrate that an embryonic exposure to vinclozolin appears to promote an epigenetic reprogramming of the male germ line that
correlates with transgenerational alterations in the testis transcriptome in subsequent generations.
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Embryonic development; VinclozolinAlthough a large number of various genes have been shown to
be associated with a variety of diseases, the majority do not have
DNA sequence mutations that can explain altered gene expres-
sion. In addition, a number of environmental factors and com-
pounds have been shown to influence a variety of diseases [1], but
few have been shown to promote DNA sequence mutations,
suggesting an alternatemechanism not involving changes inDNA
sequence [2]. Epigenetics can influence the gene expression
profiles and transcriptomes of most organs and cell types [3].
Therefore, alterations in the epigenome appear to be amajor factor
in the regulation of the transcriptomes associated with disease [4].
Epigenetics is an important mechanism in the ability of envi-
ronmental factors to influence health and disease [5].
Previous observations have demonstrated that embryonic
exposure to endocrine disruptors (i.e., vinclozolin and methoxy-
chlor) during gonadal sex determination induces a transgenera-
tional effect on adult male reproduction and sperm production
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a variety of disease states develop in a transgenerational manner
(i.e., F1–F4), including breast tumors, prostate disease, kidney
disease, and immune abnormalities [7]. Therefore, exposure to
the endocrine disruptor vinclozolin during gonadal sex deter-
mination promoted the development of a variety of adult onset
diseases [7,8]. The transgenerational phenotype was transmitted
through the male germ line [6,7]. Although females did develop
disease [7], they did not transmit this phenotype to the next
generation [6,7]. The potential contribution of the female germ
line to the transgenerational phenotype remains to be elucidated.
Alterations in the male germ-line epigenome were identified
following endocrine disruptor (i.e., vinclozolin) exposure [6].
This epigenetic reprogramming of the male germ line appears to
allow the disease phenotype to become transgenerational [6–8].
Endocrine disruptors are compounds that bind hormone re-
ceptors or effect hormone signaling to alter normal endocrinol-
ogy [9]. A large number of environmental compounds, from
plastics to pesticides, have endocrine disruptor activity [9]. The
endocrine disruptor used in the current study was vinclozolin,
which is a fungicide used in the fruit industry [10]. Vinclozolin
and its metabolites are antiandrogenic compounds that bind and
Fig. 1. E16 testis histology and cellular apoptosis. E16 testis from (A, C) F2
control and (B, D) F2 vinclozolin-generation animals for histology (A, B) and
TUNEL apoptosis staining (C, D). (E) The numbers of apoptotic germ cells/
section for F1–F3 control and vinclozolin generation E16 testes are presented,
mean±SEM, from three different experiments and compared to control wild-
type rat E16 testis (Wildtype). ⁎Statistical difference from control (pb0.05).
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shown that embryonic and early postnatal exposure to
endocrine disruptors can cause subsequent adult-onset diseases
[10–12]. The potential that endocrine disruptor actions are
mediated in part through alterations of the epigenome that are
causal in the mechanism of disease remains to be elucidated.
The biological process involved in the transgenerational
epigenetic disease phenotype involves the epigenetic program-
ming of the germ cells during gonadal sex determination
[13,14]. As the primordial germ cells migrate to the genital
ridge and colonize the bipotential gonad, their DNA becomes
demethylated [13,14]. The germ cell DNA is then remethylated
after gonadal sex determination and during gonadal differenti-
ation in a sex-specific manner [15]. Therefore, the critical period
to influence the germ-line DNA methylation is during this
epigenetic programming of the germ cells [6,15]. The ability to
induce permanent alterations in the germ-line DNA methylation
pattern is hypothesized to allow in part the phenotype to become
transgenerational [6,7]. The influence this altered germ-line
epigenome subsequently has on the transcriptomes of develop-
ing organs was investigated in the current study using the
embryonic testis as a model organ. Observations demonstrate a
transgenerational effect of the endocrine disruptor vinclozolin
on the embryonic testis transcriptome.
Results
Endocrine disruptor actions
Gestating rats were exposed to a daily intraperitoneal (ip)
injection of vinclozolin during embryonic days (E8-E14) of
embryonic development, corresponding to the period of gonadal
sex determination [6,12]. Littermate sisters were used for the
control (vehicle) and vinclozolin treatments. Eight different
gestating mothers were used for each control and vinclozolin-
treatment population. The F1 vinclozolin-generation males were
bred to F1 vinclozolin-generational females from different litters
to generate the F2 vinclozolin generation, and then F2 generation
animals were bred to generate the F3 generation. Both the control
and the vinclozolin generations were bred in similar manners. No
sibling breeding was done and control and vinclozolin-generation
animals were housed, fed, and maintained under similar con-
ditions. The E16 testes were collected for histological analysis
and RNA preparation. The morphology of the E16 testis was
similar between the control and the vinclozolin F1–F3 generation
animals (Fig. 1). The analysis of cellular apoptosis demonstrated
an increase in germ cell death between the control and the
vinclozolin F1 and F2 generation E16 testes, but not F3 (Fig. 1E).
A wild-type E16 testis level of apoptosis is also shown for
comparison. The effects on the F1 and F2 E16 testis cell apoptosis
are likely due in part to direct exposure and toxicology of the F1
embryo and F2 generation germ line. The F3 generation is the first
generation not directly exposed, so it is the first generation that is
unequivocally transgenerational (i.e., transgenerational genera-
tion). Although morphological abnormalities develop in the testis
of adult animals [6], no major effects were observed during em-
bryonic development (Fig. 1).Transgenerational transcriptome regulation
The transgenerational changes in the testis transcriptome
were investigated with a microarray analysis of the E16 testis.
The RNA from three different litters was pooled (i.e., 18–25
male pups) for an individual microarray chip and experiment.
Two different experiments (i.e., microarray chips and animal
sets) were compared for control and vinclozolin F1–F3 gen-
erations. Initially, an older rat Affymetrix RG-U34A chip that
had 8000 genes was used and results similar to those described
below were obtained (data not shown). A more recent Affy-
metrix R230 2.0 gene chip was used that contained a larger
percentage of the genome, 30,000 transcripts, and RNA from a
different set of experiments and animals. All the replicate
microarray chips were highly reproducible with R2N0.98.
Genes with a raw statistically significant (pb0.05) present call
signal greater than 75 and a greater than 1.5-fold change in
expression between control and vinclozolin-generation E16
testis samples were identified. A dendrogram analysis is shown
in Fig. 2A and demonstrates that the control F1–F3 microarrays
Fig. 2. The E16 testis transcriptome microarray analysis from F1–F3 control and vinclozolin-generation animals. (A) Dendrogram for total regulated genes with signal
above 75. (B) Dendrogram of the 196 regulated genes list. (C) The 196-gene list relative expression levels between F1–F3 controls and vinclozolin (Vincl) E16 testis.
The scales in the right margin indicate no change (black), increase (red), and decrease (green).
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to controls, the F1 vinclozolin E16 testis had 2071 genes al-
tered, the F2 vinclozolin had 1375 genes altered, and the F3
vinclozolin E16 testis had 566 genes altered (Fig. 3A). The
majority (90%) of genes altered had a decrease in expression
(Fig. 2A), with approximately 10% having an increase in
expression. A comparison of F1–F3 vinclozolin-generation E16
testis transcriptome changes demonstrated that 196 genes hadsimilar altered expression in all generations (Fig. 3A). There-
fore, the vinclozolin F1–F3 generation animals had similar
changes in the E16 testis transcriptome for these 196 genes
(Fig. 2B), and most were decreased in comparison to the control
generations (Fig. 2C). Due to the potential toxicology of
vinclozolin in the F1 generation animals it is not surprising that
a larger number of genes were affected (i.e., 2071). Since the F2
generation germ line was also exposed directly to vinclozolin,
Fig. 3. Categorization of the F1–F3 regulated genes. (A) Venn diagram with total regulated (N1.5-fold change between control and vinclozolin) genes listed and the
overlap, with 196 shown to be consistent among the F1–F3 generations. (B) Categorization into functionally related gene groups with the number of genes (blue down-
regulated and yellow up-regulated).
Fig. 4. Methyltransferase gene expression in the F1–F3 control and vinclozolin-
generation E16 testis. Relative expression is presented for the specific genes
after microarray analysis. The values for F1 and F2 vinclozolin-generation gene
expression for Dnmt3A, Dmap1, Dnmt2, Ehmt1, and Rnmt were statistically
different from the respective control-generation values (pb0.05), with Dnmt1
statistically different in the F2 vinclozolin-generation samples and Trmt1 not
statistically different in any generation.
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(i.e., 1375). Although the F2 generation could involve trans-
generational effects, the F3 generation is the first generation that
has had no direct exposure, so it is unequivocally transgenera-
tional. Therefore, the F3 generation genes have a transgenera-
tional change in expression. A preliminary analysis of the F4
generation E16 testis transcriptome was performed; however,
the arrays were performed at different times than the F1–F3
arrays, limiting direct comparison (data not shown). This F4
generation experiment would determine and potentially further
decline in transgenerational effects.
Previous observations suggested the transgenerational disease
phenotype was transmitted through the paternal line [6,7]. A
vinclozolin outcross (VOC) experiment with an F2 vinclozolin-
generation male and a wild-type female was generated for a
microarray analysis of the F3 VOC E16 testis. Comparison of the
altered transcriptomes demonstrated that the F3 VOC had
alterations similar to those of the F1–F3 vinclozolin E16 testis
with 165 genes of the 196-gene list being similar (Supplemental
Table S1). Therefore, as observed with the adult disease pheno-
Table 1
Gene category and symbol Microarray signal GenBank No. Description/function
Control Vinclozolin
(A) F1 generation regulated epigenetic-associated genes
Methylation
Dnmt3A 110 44 AA956455 DNA methyltransferase 3A
Dnmt2 68 47 AI17081 DNA methyltransferase 2
Hrmt113 42 82 AF059530 Heterogeneous nuclear ribonucleoprotein methyltransferase-like 3
Gadd45A 79 52 NM_024127 Growth arrest and DNA-damage-inducible 45α
Histone modification
Mgea5 323 185 BF548107 Meningioma expressed antigen 5 (hyaluronidase)
RGD1311017_pre 82 35 B1289182 Similar to multiple HAT domains (predicted)
Hdac1 563 200 AW530195 Histone deacetylase 1 (predicted)
Ash1l_pre 144 57 BG663056 Ash1 (absent, small, or homeotic)-like (predicted)
Ehmt1_pre 496 321 BM389055 Euchromatic histone methyltransferase 1 (predicted)
LOC679252 235 141 A1070638 Similar to histone–lysine N-methyltransferase, H3
Chromatin remodeling
Rere 75 35 NM_053885 Arginine–glutamic acid dipeptide (RE) repeats
Mta1 272 157 AJ132046 Metastasis-associated 1
Smarca5_l 215 139 BF557855 SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin,
subfamily a, member 5 (predicted)
Chd1_pre 378 115 BF396625 Chromodomain helicase DNA binding protein 1 (predicted)
Chd2_pre 178 95 BF396633 Chromodomain helicase DNA binding protein 2 (predicted)
Chd6_pre 57 93 BF396625 Chromodomain helicase DNA binding protein 6 (predicted)
Shprh_pre 97 60 BE104039 SNF2 histone linker PHD RING helicase (predicted)
Transcription regulation
Epc2_pre 233 113 AW918173 Enhancer of polycomb homolog 2 (predicted)
Pcgf6 419 256 AA858786 Polycomb group ring finger 6
(B) F2 generation regulated epigenetic-associated genes
Methylation
Dnmt3A 127 56 AA956455 DNA methyltransferase 2
Dnmt1 558 417 AI179516 DNA (cytosine-5) methyltransferase 1
Tpmt 138 69 BG381002 Leucine carboxyl methyltransferase 1
Histone modification
Ash1l_pre 139 54 BG663056 Ash1 (absent, small, or homeotic)-like (predicted)
Hdac1 532 279 AW530195 Histone deacetylase 1
Ehmt1 493 333 BM3890 Euchromatic histone methyltransferase 1
Jmjd3_pre 360 225 BE118720 Jumonji domain-containing 3 (predicted)
RGD1311017_pre 91 41 BI289182 Similar to multiple HAT domains (predicted)
LOC679252 236 129 AI070638 Similar to histone–lysine N-methyltransferase, H3
RGD1566399_pre 273 174 BE098769 Similar to MYST histone acetyltransferase monocytic leukemia 4 (predicted)
Chromatin remodeling
Cbx1_pre 330 98 BF389675 Chromobox homolog 1 (Drosophila HP1β) (predicted)
Chd1_pre 386 158 BF396625 Chromodomain helicase DNA-binding protein 1 (predicted)
Chd4 173 86 BF412612 Chromodomain helicase DNA-binding protein 4
RGD1561537_pred 85 41 BF397269 Similar to putative repair and recombination helicase RAD26L (predicted)
Smarca4 243 160 BM385181 SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin,
subfamily a, member 4
Transcriptional regulation
Epc2_pre 244 140 AW918173 Enhancer of polycomb homolog 2 (predicted)
Pcgf2_pre 99 655 BI294621 Polycomb group ring finger 2 (predicted)
(C) F3 generation regulated epigenetic-associated genes
Histone modification
RGD1566399_pre 273 174 BE098769 Similar to MYST histone acetyltransferase monocytic leukemia 4 (predicted)
Hdac4_pre 106 62 BF419085 Histone deacetylase 4 (predicted)
Ehmt1_pre 508 330 BM389055 Euchromatic histone methyltransferase 1 (predicted)
LOC49817 215 143 Al235220 Similar to SET domain-containing protein
Hist1h4b 86 144 BM986536 Germinal histone H4 gene
Chromatin remodeling
Smarca2 90 144 BF547582 SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin,
subfamily a, member 2
Chd7_pre 100 66 AI599104 Chromodomain helicase DNA binding protein 7 (predicted)
Statistically significant (pb0.05) changes (N1.5-fold) in gene expression with the genes in bold having a decrease in the vinclozolin-generation E16 testis. The italic
gene is in common among the F1, F2, and F3 generations.
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appear to be transmitted primarily through the paternal line.
Potential contributions of the female germ line remain to be
elucidated and no experiments on the embryonic female gonad
transcriptome have been performed.
The 196 genes that were altered transgenerationally in the F1,
F2, and F3 vinclozolin generations were further analyzed. Cluster
analysis of categories of genes demonstrated that genes involved
in transcriptional regulation, signal transduction, and cytoskeleton
were highly represented (Fig. 3B). Other gene categories re-
presented included metabolism, cell cycle, development, pro-
teolysis, and apoptosis. Expressed sequence tags and unknown
genes were also highly represented. The majority (90%)
of genes were down-regulated in the vinclozolin-generation
(F1–F3) E16 testis, with 10% up-regulated (Figs. 2 and 3B).Fig. 5. Semiquantitative PCR analysis of (A and B) Dnmt3A, (A and C) Dnmt1, (A
representative electrophoretic gel of the PCRproducts is presented (A) and the combined
The means±SEM are presented, with asterisks indicating a statistical difference (pb0.The full list of 196 genes and their relative signals is presented
in Supplemental Table S1. A subset of genes (i.e., 90) from the
196-gene list that were significantly down-regulated and/or
silenced in the F1–F3 vinclozolin-generation E16 testis is
shown in Supplemental Table S2. These genes provide can-
didates for direct or indirect epigenetic modification that may
silence gene expression.
Sites of potential epigenetic regulation
DNA methylation patterns are established during embryogen-
esis through cooperation of a family of methyltransferases
(Dnmt's) that includes Dnmt1, Dnmt2, Dnmt3A, Dnmt3B, and
Dnmt3L [16–18]. There are also Dnmt-associated proteins (e.g.,
Dmap1) and methyltransferases for histones (e.g., euchromaticand D) Dnmt3L, (A and E) Ehmt1, and (A) the constitutively expressed S2. A
data from three different experimentswith normalization to S2 are presented (B–E).
05) between control and vinclozolin-generation F1–F3 E16 expression levels.
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transferase, Rnmt; and tRNA-methyltransferase 1, Trmt1). These
methyltransferases in part regulate the epigenome of developing
organs and the germ line. The expression of several of these
methyltransferases in control and vinclozolin F1–F3 generation
E16 testis is shown in Fig. 4. All the genes had a statistically
significant change in expression in the F1 or F2 vinclozolin-
generation E16 testis compared to control (Table 1). The DNA
methyltransferases and histone methyltransferase (Ehmt1) all
decreased, with the most dramatic change in Dnmt3A (Fig. 4).
Dnmt3A has been shown to be essential in paternal and maternal
imprinting of the germ line [19]. The Dmap1, Trmt1, and Rnmt1
genes all increased in expression in the vinclozolin samples.
Therefore, the alteration in the epigenome induced by vinclozolin
may be in part due to alterations in methyltransferase activity
during F1 generation embryonic exposure. Interestingly, the F3
generation E16 testis gene expression levels appear to be returning
to normal control levels, except for Ehmt1 (Fig. 4). Therefore,
the initial effects may be in part mediated through alterations in
normal methyltransferase activity, but the transgenerational
transmission appears to be through an alternate mechanism, such
as a modified epigenome in the germ line.
To confirm the microarray analysis a semiquantitative PCR
procedure was used to examine Dnmt1, Dnmt3A, and Ehmt1
expression. Dnmt3L is a germ-cell-specific isoform of DNA
methyltransferase [17,18] that was not on themicroarray, so it was
analyzed with the PCR procedure. The E16 testes from control
and vinclozolin F1–F3 generation rats were collected and ana-
lyzed. The semiquantitative PCR procedure was performed in
three different experiments andwith three different RNA samples.
The analysis confirmed the microarray observations and demon-
strated the transient F1 generation decrease in the expression of
Dnmt1, Dnmt3A, Dnmt3L, and Ehmt1 (Fig. 5). Therefore, the
microarray data were confirmed with this semiquantitative PCR
analysis of Dnmt1, Dnmt3A, and Ehmt1. The Dnmt3L germ-cell-
specific isoform was decreased in a manner similar to that of
Dnmt3A in the F1 and F2 generation. Interestingly, some genes
(e.g., Dmnt3A) were transiently decreased in the F1 or F2 gen-
eration and returned to normal levels by the F3 generation, while
others (e.g., Dmnt3L) were decreased for all generations.
The hypothesis that “vinclozolin exposure during the tran-
sition from hypomethylation to hypermethylation of the fetal
germ cells reprograms the epigenome of the male germ line” is
speculated to promote the transcriptome effects and the adult-
onset disease phenotype as becoming transgenerational. There-
fore, a select group of genes previously shown to be involved in
the epigenetic regulation of the genome was analyzed, including
genes associated with DNA methylation, histone modification,
and chromatin remodeling. Those genes involved in epigenetic
regulation and found to have altered expression in the F1, F2, or
F3 generation E16 testis are shown in Table 1. Interestingly, 19
epigenetic-associated genes had altered expression in the F1
vinclozolin-generation compared to control (Table 1A). The F2
vinclozolin-generation E16 testis had 17 genes altered, with
8 genes in common with F1 and 1 gene in common with F3
(Table 1B). Seven distinct epigenetic-associated genes were
altered in the F3 generation (Table 1C). Genes were represented ineach category and only one, Ehmt1, was in common among F1,
F2, and F3 vinclozolin generations. Observations suggest that the
direct actions of vinclozolin on the F1 generation affect an
increased number of epigenetic-associated genes, which are
speculated to be involved in the reprogramming of the germ-line
epigenome. In contrast, the F3 generation altered genes are dis-
tinct and associated with the transgenerational transcriptome and
phenotype, but not necessarily involved in the direct actions of
vinclozolin. Therefore, the actions of vinclozolin on the F1 gen-
eration appear to modify the epigenetic reprogramming to in part
promote a permanent change (e.g., imprinting-like status) that
causes epigenome alterations to be transmitted transgeneration-
ally to subsequent F3 generations. The transcriptome changes in
the F1 versus F3 generation contain some gene alterations in
common, but many that are distinct.
Discussion
Endocrine disruptor actions
Endocrine disruptors are a class of compounds that alter
hormone actions and endocrinology [8–10]. Many environmental
compounds, from fungicides to plastics, have endocrine disruptor
activity [10,20]. Embryonic and early postnatal exposure to these
compounds has been shown to promote adult-onset disease in
numerous species [1,6,9,20,21]. The frequency of transgenera-
tional disease induction and reproducibility of the phenomenon
[6,7] suggest DNA sequence mutations are not likely the causal
factor. A mechanism to consider is an alteration in the epigenetic
programming (e.g.,DNAmethylation) of the genome. Epigenetics
(e.g., DNA methylation) has been shown to have a significant
impact on the regulation of gene expression and the transcriptome
[22,23]. The possibility that these environmental compounds
promote an alteration in the epigenome (i.e., DNA methylation
pattern) that then modifies the transcriptome associated with
disease development was investigated in this study.
Two potential epigenetic sites of action for environmental
toxicants need to be considered. The first is during the active
development of a specific organ, when the epigenome and trans-
criptome are going through a cascade of developmental stages to
establish eventually the adult organ transcriptome and physiol-
ogy. In the event a factor reprograms or alters an epigenetically
labile site or metastable allele of the epigenome during this
development, the adult organ may not have the proper trans-
criptome and become susceptible to developing disease. This
epigenetically induced adult-onset disease state would not be
passed to subsequent generations, but may be a significant factor
in disease etiology [24]. The second major epigenetic site of
action involves reprogramming the epigenome of the germ line
[6,8]. The embryonic programming of the genome during sex
determination could be modified to promote an abnormal
epigenome. In the event this modified epigenetic program (i.e.,
DNA methylation) became imprinted all subsequent generation
programming would be influenced. Since the primordial germ
cells undergo a demethylation prior to sex determination and then
remethylation in a sex-specific manner [13–15] during gonadal
sex differentiation, the germ cells at this time could be sensitive to
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factors could promote a transgenerational phenotype if the germ-
line reprogramming were inherited [5,8]. Observations demon-
strate that the endocrine disruptor vinclozolin can alter the
epigenome of the male germ line transgenerationally. The ability
of this altered epigenome to promote a transgenerational
epigenetic alteration in the transcriptome is speculated to be the
mechanism behind the subsequent development of heritable
adult-onset disease [7].
Transgenerational transcriptome regulation
As a model organ the embryonic testis was selected to
examine the transgenerational epigenetic transcriptome. The F1,
F2, and F3 control and vinclozolin-generation E16 testis was
obtained for analysis. Although morphological abnormalities
were observed in adult animals [6], no histological changes were
observed in the E16 testis. As seen with the adult animals [6], the
vinclozolin F1 and F2 generation E16 testis also had increased
germ-cell apoptosis, but the F3 generation did not. Interestingly,
the transcriptomes of F1–F3 vinclozolin-generation E16 testis
were significantly altered. A set of 196 genes was found to be
consistently altered in the F1–F3 generation animals. Since the
F1 generation embryo and F2 generation germ line are directly
exposed to vinclozolin, the number of genes affected is spec-
ulated to be higher in these generations’ E16 testis. The F3
generation is the first that is directly transgenerational (i.e., not
having direct exposure) and the observations demonstrate the
presence of a transgenerational epigenetic effect on the trans-
criptome. Developing organs have a cascade of changes in the
epigenome and transcriptome that lead to the adult stage of
differentiation. Therefore, the transgenerational epigenetic
changes in the transcriptome will be distinct at different devel-
opmental stages and for different organs and cell types.
Sites of potential epigenetic regulation
Although a number of different epigenetic regulatory mech-
anisms exist, the primary heritable epigenetic mechanism in-
volves DNA methylation. The potential role of other epigenetic
mechanisms (e.g., histone modification) remains to be thor-
oughly established. DNA methylation patterns are established
during embryogenesis through the cooperation of methyltrans-
ferases and associated proteins [16]. Dnmt1 is responsible for
maintenance of methylation patterns throughout DNA replica-
tion (i.e., specific to hemimethylated sequences) and is localized
in nuclear somatic tissues [25]. Dnmt2 may be involved in
embryonic stem cells [26] and potential RNA methylation [27].
Dnmt3A and Dnmt3B are involved in active de novo DNA
methylation at CpG sites [28]. Dnmt3 and Dnmt1 can cooperate
and interact to regulate DNA methylation [29]. Dnmt3A inter-
action with Dnmt3L, the germ-line-specific Dnmt, appears to be
responsible for imprinting of the germ line [29]. Dnmt3A has
been shown to influence the imprinting of a number of genes in
the germ line [28–31]. Although Dnmt3L does not alone have
methyltransferase activity, abnormal expression of Dnmt3L
alters imprinting and allelic gene expression [18,32]. A hetero-dimer of Dmnt3A and Dmnt3L appears to have a role in DNA
methylation and the structure suggests unique specificity for the
methylation of imprinted genes in the germ line [33]. The current
study demonstrates that vinclozolin exposure during sex
determination alters the expression of Dnmt's in the F1 and F2
generations, with a return to more normal levels by the F3
generation. A dramatic effect on Dnmt3A and Dnmt3L was
observed and correlates with its role in imprinting of the germ
line [19]. Therefore, alterations in the epigenome of the pri-
mordial germ cell and E16 testis transcriptome are speculated to
involve in part alterations in Dnmt expression and activity. The
transgenerational nature of the phenotype by the F3 generation
likely does not involve Dnmt’s directly, but possible permanent
alterations in the epigenome of the germ line. This is related to
the proposal that vinclozolin promotes an epigenetic reprogram-
ming of the male germ line involving an altered DNA meth-
ylation on newly induced imprinted-like DNA sequences [5,6].
In the F1 generation exposure the germ line is reprogrammed to
develop these new imprinted-like sites that then transgener-
ationally transmit the alteration in the male germ-line epigenome
to subsequent generations. A known imprinted gene (i.e., H19)
was found not to have a change in methylation after vinclozolin
exposure, such that the reprogrammingmay involve the induction
of new sites [34]. Therefore, the epigenetic transgenerational
phenotype initially involves effects on the DNA methylation
machinery (i.e., methyltransferases) and then appears to be trans-
generationally transmitted through permanent changes in the
epigenome.
A combination of factors and proteins is likely involved in the
altered epigenetic programming observed and not simply
reflected in a regulation of DNA methyltransferases alone.
Additional genes associated with epigenetic regulation were
shown to be altered in the F1 vinclozolin-generation E16 testis. In
contrast, a small distinct set of epigenetic-associated genes was
altered in the F3 vinclozolin generation, with only one gene (i.e.,
Ehmt1) in common among the F1, F2, and F3 generations. All
three major epigenetic categories of DNA methylation, histone
modification, and chromatin remodeling were represented in the
affected gene list. An interesting example of a histone methyl-
transferase analyzed is euchromatic histone methyltransferase 1
(Ehmt1), which can promote histone methylation to suppress
transcription [35] and indirectly influence DNAmethylation [36].
Ehmt1 expression in the F1–F3 vinclozolin-generation E16 testis
was found to decrease, which suggests that a combination of
DNA and histonemethyltransferaseswill likely be involved in the
initial actions of vinclozolin. Therefore, the direct exposure to
vinclozolin in the F1 generation altered the expression of a sig-
nificant number of epigenetic-associated genes that are presumed
to be responsible in part for the reprogramming of the germ-line
epigenome. Those epigenetic-associated genes altered in the F3
vinclozolin generation are likely associated with the transgenera-
tional transcriptome. Observations suggest that the methylation
and epigenetic machinery is modified after vinclozolin exposure,
but the specificmechanisms involved in the reprogramming of the
germ-line epigenome remain to be elucidated.
Previously, we have shown that the endocrine disruptor
vinclozolin after embryonic exposure prior to and during gonadal
38 M.D. Anway et al. / Genomics 91 (2008) 30–40sex differentiation promotes adult-onset disease involving sper-
matogenic cell defects andmale fertility [6], as well as a variety of
other disease states [6]. Investigation of the transgenerational
sperm epigenome identified genes/DNA sequences with potential
methylation characteristics in F3 vinclozolin-generation animals
[7]. The current study demonstrates a transgenerational effect on
the transcriptome of the developing embryonic testis. Therefore,
the mechanism proposed is that the environmental factor (i.e.,
endocrine disruptor vinclozolin) acts on the embryonic gonad
during gonadal sex determination/differentiation to alter the
epigenetic programming of the male germ line [6–8]. This altered
germ-line epigenome appears, in a transgenerational manner,
subsequently to modify the transcriptomes of developing organs
and is speculated to result in adult-onset disease. The epigenetic
effects of environmental exposures could provide a mechanism
for many toxicant exposure phenotypes observed [5]. Although
the level of vinclozolin used in the current study exceeds that
observed in the environment, such that no conclusion on toxi-
cology can be made, the phenomenon of developing a trans-
generational epigenetic effect on the transcriptome is critical to
understanding the potential mechanisms involved in toxicology
and disease. The ability of an environmental factor to influence
the transgenerational epigenetic programming of an organs
transcriptome provides a critical factor in disease etiology not
previously considered. Further analysis of this transgenerational
epigenetic transcriptome now requires individual organ systems
and disease states to be investigated.
Materials and methods
In vivo procedures
Gestating outbred Sprague–Dawley mother rats from timed pregnant
colonies housed at the Washington State University vivarium were given ip
injections of vinclozolin (100 mg/kg/day) from embryonic day 8 to 14 of
gestation (i.e., F0 generation) as previously described [37]. The sperm-positive
vaginal smear date was taken as embryonic day 0. Gestating control mothers (i.e.,
F0 generation) received vehicle alone (i.e., sesame oil and DMSO). At least eight
lines (individual F0 injected females) were generated for controls and eight lines
for vinclozolin generations for these analyses. The F1–F3 generation animals
derived from a vinclozolin-exposed F0 mother are referred to as vinclozolin-
generation animals, while those from control F0mothers are identified as control-
generation animals. The testes from male rats from control and vinclozolin
generations were collected at E16 for analysis. Adult F1 vinclozolin-generation
(offspring from F0 mothers) males were bred to F1 vinclozolin-generation
females to generate the F2 vinclozolin generation. Adult F2 vinclozolin-
generation males were bred to F2 vinclozolin-generation females to generate the
F3 vinclozolin generation. Rats for the control groups (i.e., generations F1–F3)
were bred in the same manner for all the generations. No inbreeding or sibling
crosses were generated. The VOC group was generated by breeding the F2
vinclozolin-generation males with wild-type females (total of six litters). Wild-
type E16 litters were collected from wild-type male and female breedings.
Pregnant wild-type females did not receive any injections andwere used to verify
the effects of the treatment. All procedures were approved by the Washington
State University Animal Use and Care Committee.
Histology
Tissues were fixed in Bouin's (Sigma, St. Louis, MO, USA) for 1 h,
embedded in paraffin, and sectioned. Sections were stained with hematoxylin
and eosin according to standard procedures. The Center for Reproductive
Biology, Histology Core Laboratory, assisted with these procedures. The animalnumbers were n=6 for vinclozolin and n=6 for controls from three different
lines (i.e., F0 injected mothers) from each generation (F1–F3).
Detection of cell apoptosis
To detect apoptotic cells in testis sections, the Fluorescein In Situ Cell Death
Detection Kit (Roche Applied Science, Indianapolis, IN, USA) was utilized
[37]. This system measures the fragmented DNA from apoptotic cells by
enzymatically incorporating fluorescein-12–dUTP at the 3′-OH DNA ends
using the enzyme terminal deoxynucleotidyl transferase, which forms a
polymeric tail using the principle of the TUNEL assay. Fluorescent apoptotic
cells were imaged on a confocal microscope and the number of apoptotic cells
per testis cross section was determined. A minimum of n=6 for vinclozolin and
n=4 for controls for each generation was used. All cross sections used for
TUNEL analysis had normal testis morphology.
Microarray analysis and bioinformatics
RNAwas hybridized to the Affymetrix (Affymetrix, Santa Clara, CA, USA)
Rat 230 2.0 gene chip. The Genomics Core in the Center for Reproductive
Biology at Washington State University performed the analysis as previously
described [38,39]. Briefly, RNA from control and vinclozolin-generation E16
testis was reverse transcribed into cDNA and cDNAwas transcribed into biotin-
labeledRNA. Biotin-labeled RNAwas then hybridized to the Affymetrix Rat 230
2.0 gene chips. Biotinylated RNA was then visualized by labeling with
phycoerythrin-coupled avidin. The microarray chip was scanned on an
Affymetrix Gene Chip Scanner 3000 (Affymetrix). The microarray image data
were converted to numerical data with GeneChip operating software (GCOS;
version 1.1; Affymetrix) using a probe set scaling factor of 125. An absolute
analysis was performed with GCOS to assess the relative abundance of the
transcripts based on signal and detection calls (present, absent, or marginal). This
information was imported into Genespring software (Silicon Genetics, Redwood
City, CA, USA) and normalized using the recommended defaults. This includes
setting signal values below 0.01 to a value of 0.01, total chip normalization to the
50th percentile, and normalization of each chip to the median. Unless otherwise
indicated, for a transcript to be considered present it had to both be flagged as
present in the GCOS present/absent call and have an expression level greater than
75. Briefly, the 16 sets of oligonucleotides for a specific gene were used to make
comparisons of a signal to determine a present call statistically using a one-sided
Wilcoxon signed rank test. For a transcript to be considered changed between
treatment groups it had to exhibit at least a 1.5-fold change between the means of
the treatments and have a Student t test p value ≤0.05 between treatments. The
raw signal cutoff was between 75. Therefore, the data presented are for genes that
were determined to be statistically present and found to have a statistically
different change.
Two different experiments were performed involving two different sets of
animals, RNA sample preparations, andmicroarray chips. Therefore, two control
and vinclozolin-generation E16 testis samples were analyzed on two different
chips. This allowed a 2×2 factorial comparison with all present/absent calls and
changes in expression to be statistically significant for further analysis. The R2
for the comparison between microarray chips was found to be R2N0.94, which
indicated negligible total variability between chips, experiments, and samples.
This R2 value and statistical analysis indicated the chip number used was
appropriate. The number of chips required for specific experiments has been
previously reviewed [40]. Previous studies have demonstrated that microarray
data is validated with quantitative PCR data [39,41]. Due to the presence of 16
different oligonucleotide sets for each specific gene being used on the microarray
versus only a single primer set for a gene in a quantitative PCR, the microarray is
more effective at eliminating false positive or negative data and provides a more
robust quantitation of changes in gene expression. However, validation of
microarray data was performedwith selected genes using a semiquantitative PCR
procedure. Although the magnitude of the change can vary, the absence or
presence of a change is generally consistent. A number of the methyltransferases
(i.e., Dnmt1, Dnmt3L, Dnmt3A, and Ehmt1) were selected to perform a
semiquantitative PCR analysis to confirm the microarray data. The primer sets
used for the genes were Dnmt1, forward 5′-GTGGGATGGCTTCTTCAGTA-3′
and reverse 5′-GGCTTGGTCACAAAACAAAC-3′; Dnmt3L, forward 5′-CG-
CTGAAGTACGTGGAAGAT-3′ and reverse 5′-ACTTGGGTTTGCAGAGA-
39M.D. Anway et al. / Genomics 91 (2008) 30–40CTG-3′; Dnmt3A, forward 5′-TTGGCTTCCCTGTCCACTAC-3′ and reverse
5′-ATGATGTCCAACCCTTCTGC-3′; Ehmt1, forward 5′-ATGTAAATGGC-
GAGAGCTTG-3′ and reverse 5′-TTCCTGGGGATGACTTACAA-3′; and S2,
forward 5′-GCTCGTGGAGGTAAAGCTGA-3′ and reverse 5′-TGAGAC-
GAACCAGCACAGAG-3′. Similar observations were made with this semi-
quantitative PCR procedure and the microarray analysis.
Statistical analysis
The data from apoptotic cell numbers were analyzed using the SAS program.
The values were expressed as the mean±SEM. Statistical analysis was
performed and the difference between the means of treatments and respective
controls was determined using a Student t test. In vivo experiments were
repeated with three to six individuals for each data point. A statistically
significant difference was confirmed at pb0.05.
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